Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborators:

Gilead Sciences

Roche Pharma AG

Information provided by (Responsible Party):

French National Agency for Research on AIDS and Viral Hepatitis

ClinicalTrials.gov Identifier:

NCT00391638

First received: October 23, 2006

Last updated: February 21, 2012

Last verified: February 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	October 2012
Primary Completion Date:	May 2011 (Final data collection date for primary outcome measure)